scholarly journals Carbohydrate antigen 125 and carcinoembryonic antigen in the differentiation of tuberculous peritonitis and peritonitis carcinomatosa

Oncotarget ◽  
2017 ◽  
Vol 8 (44) ◽  
pp. 78068-78075 ◽  
Author(s):  
Huan Tong ◽  
Yang Tai ◽  
Cheng Ye ◽  
Hao Wu ◽  
Lin-Hao Zhang ◽  
...  
Keyword(s):  
Carcinoembryonic Antigen ◽  
Carbohydrate Antigen ◽  
Tuberculous Peritonitis ◽  
Carbohydrate Antigen 125 ◽  
Peritonitis Carcinomatosa

scholarly journals Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder

2020 ◽  
Vol 19 (1) ◽  
pp. 4
Author(s):  
Amit Gupta ◽  
Saumya Agrawal ◽  
Sweety Gupta ◽  
Bela Goyal ◽  
RohikAnjum T. Siddeek ◽  
...  
Keyword(s):  
Gall Bladder ◽  
Carcinoembryonic Antigen ◽  
Carbohydrate Antigen ◽  
Carbohydrate Antigen 125 ◽  
Carcinoma Gall Bladder

Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125

2005 ◽  
Vol 12 (2) ◽  
pp. 214-216 ◽  
Author(s):  
TAKEHISA ONISHI ◽  
OMAR E FRANCO ◽  
TAKUJI SHIBAHARA ◽  
KIMINOBU ARIMA ◽  
YOSHIKI SUGIMURA
Keyword(s):  
Carcinoembryonic Antigen ◽  
Renal Pelvis ◽  
Papillary Adenocarcinoma ◽  
Carbohydrate Antigen ◽  
Carbohydrate Antigen 125

scholarly journals Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Huijuan Meng ◽  
Yulan Zhang ◽  
Youguo Chen
Keyword(s):  
Cervical Cancer ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Carcinoembryonic Antigen ◽  
Cancer Patients ◽  
Carbohydrate Antigen ◽  
Advanced Cervical Cancer ◽  
Squamous Cell Carcinoma Antigen ◽  
Carbohydrate Antigen 125 ◽  
Combined Test

Objective. To explore the diagnosis value of colposcope combined with serum squamous cell carcinoma antigen (SCC-Ag), carbohydrate antigen 125 (CA125), and carcinoembryonic antigen (CEA) for moderate to advanced cervical cancer patients treated with modified Fuzheng Peiyuan decoction. Methods. The clinical data of 43 moderate to advanced cervical cancer patients treated in Suzhou Hospital of Traditional Chinese Medicine from July 2018 to July 2019 were selected for the retrospective analysis, and 43 healthy women undergoing physical examination in our medical center in the same period were selected as the control group. The cervical cancer patients accepted the modified Fuzheng Peiyuan decoction treatment, the detection of SCC-Ag, CA125, and CEA and colposcope examination were performed to all research subjects, and the changes in indicators such as KPS scores and lesion perfusion parameters in cervical cancer patients before and after treatment were monitored, so as to analysis the clinical diagnosis value of combined diagnosis in treated patients. Results. After treatment, the mean KPS scores were greatly higher and various blood perfusion parameters of lesions and serum SCC-Ag, CA125, and CEA levels were remarkably lower than before ( P value <0.001 for all); the area under the curve of combined test was significantly larger than that of single test, and the sensitivity and specificity of the combined test were the highest; and after medication, the total incidence rate of toxic and side effects was 11.63%. Conclusion. Fuzheng Peiyuan decoction has significant effect in treating moderate to advanced cervical cancer, and colposcope combined with serum test presents more accurate and credible diagnosis results and has great significance for future treatment, which shall be promoted and applied.

Sign in / Sign up

Export Citation Format

Share Document